Business
UBS Reiterates Buy Rating on UnitedHealth, Sees Strong 2026 Earnings
UBS maintains a Buy rating on UnitedHealth Group with a $410 price target, citing management's confidence in 2026 earnings seasonality and medical loss ratios.

